Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Infectious Diseases and Therapy|October 2, 2014
Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized FormulationGabriel J Robbie, Doris Makari, Brian Harris, et al.Infectious Diseases and Therapy|October 10, 2014
Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic ReviewColleen Wegzyn, Lim Kai Toh, Gerard Notario, et al.The Oncologist|October 17, 2024
Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectivenessAdam Brufsky, Xianchen Liu, Benjamin Li, et al.Cardio-Oncology (London, England)|January 28, 2025
CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 - metastatic breast cancerSusan Dent, Avirup Guha, Heather Moore, et al.Breast Cancer Research and Treatment|August 23, 2024
Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancerAdam Brufsky, Marilyn L Kwan, Rickard Sandin, et al.Cancer Medicine|March 27, 2025
Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2- Metastatic Breast CancerAdam M Brufsky, Rickard Sandin, Stella Stergiopoulos, et al.Journal of Comparative Effectiveness Research|September 10, 2024
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclibImtiaz A Samjoo, Alexandra Hall, Connie Chen, et al.The Journal of Urology|June 20, 2020
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 InhibitorsGuru Sonpavde, Juliane Manitz, Chen Gao, et al.Pageof 2